-+ 0.00%
-+ 0.00%
-+ 0.00%

PetMed Express Announces That Its CEO Sandra Campos And CFO Robyn D'Elia Have Resigned. Leslie C.G. Campbell Has Been Appointed Interim CEO And Douglas Krulik Has Been Appointed Interim Principal Financial Officer

Benzinga·08/12/2025 20:28:32
Listen to the news

PetMed Express, Inc. (the "Company") dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D'Elia, have resigned from their positions and employment with the Company.

As part of the leadership changes, Leslie C.G. Campbell, the Chair of the Company's Board of Directors (the "Board"), has assumed the role of Interim Chief Executive Officer, and Douglas Krulik, the Company's Chief Accounting Officer, has assumed the role of Interim Principal Financial Officer. The Company has initiated a search for a new Chief Executive Officer and Chief Financial Officer.

In connection with their resignations from the Company, Ms. Campos and Ms. D'Elia each entered into a separation agreement with the Company on August 11, 2025 under which, in exchange for a general release and waiver of claims against the Company, they will receive severance payments in the form of continuation of their current base salary for thirteen months and the accelerated vesting of a portion of their unvested restricted stock units substantially in accordance with the severance terms of their respective employment agreements. They have also agreed to provide consulting services to the Company for a period of three months on an as-needed basis. A more detailed summary of the terms of the separation agreements is set forth in the Current Report on Form 8-K filed by the Company today with the SEC.

The Company also announced that, in connection with her resignation, Ms. Campos resigned as a member of the Board of Directors effective as of August 11, 2025, whereupon the Board reduced the number of directors on the Board to five members if and until the Board determines to appoint or nominate additional directors. Following her transition to Interim Chief Executive Officer, Ms. Campbell will remain as Chair of the Board of Directors but will resign from both the Board's Audit Committee and the Compensation and Human Capital Committee. Justin Mennen has been appointed by the Board as its Lead Independent Director. In addition, Peter Batushansky has been appointed to Chair of the Board's Audit Committee, and Leah Solivan has been appointed to Chair of the Board's Compensation and Human Capital Committee.